Aiming for complete data

Slides:



Advertisements
Similar presentations
Patient and Public Event 4 th September Welcome Background & reason for meeting Outline of the study Your Experience & thoughts Trial Intervention.
Advertisements

Patient Follow-up & Streamlining Data Collection.
E-Portfolio July2014 Managing Multi-source Feedback.
1 Unit & District Tools Phase 1. 2 To access the new Unit and District Tools, you will need to click on the link embedded in the MyScouting Flash page.
ATLAS Steering Committee: 24 September 2005 Steering Committee meeting, 24 th September 2005 University of Oxford Examination Schools.
Welcome to ACST-2! Guidance & Useful Information
McKesson Upgrade - ER 11/12 What is ER 11/12? ER is “Enterprise Release” and 11/12 is the software version. This release will upgrade many parts of the.
Trial Procedures and Forms
HOW TO REGISTER A TEAM Version 1.04 Rev Season 1v1.04 Rev ASA’s Online Registration.
Key Information about CervicalCheck for Non-Medical Staff in Primary Care.
1.When a job comes in office it goes to Customer Service 2.If you are sending in a payment whether the job is in house or on it’s way, it comes to Customer.
Recruitment It’s good to see more centres have got started (Hillingdon, Weston-s-Mare & Manchester General). We are applying to the MRC for an extension.
28th April 2008 What scans to perform for patients entered in IST3 and how to send them to the trial office Eleni Sakka Joanna Wardlaw Peter Sandercock.
IN-PATIENT WARFARIN CONTROL at PINDERFIELDS GENERAL HOSPITAL, WAKEFIELD BY PHILIP BOOTH SENIOR B.M.S. ANTICOAGULANT CO-ORDINATOR.
Formic software training for the SCOOP study Mikey Desai, Training Consultant, Formic Ltd Liz Lenaghan, SCOOP Study Manager, UEA.
 When you receive a new you will be shown a highlighted in yellow box where your can be found  To open your new just double click.
GWASANAETHAU IECHYD A DIOGELWCH / HEALTH AND SAFETY SERVICES HOW TO COMPLETE AN ACCIDENT & INCIDENT FORM Essential elements of an Accident & Incident Form.
Mette Krag, MD, coordinating investigator
Module Three: Identifying your Patient in SIS. Introduction – Search for 1 st T Specimen The Search for 1 st T Specimen screen is used to access your.
VOLUNTEER CONFERENCE REGIONAL NEWSLETTERS Lesley Lenssen and Andrew Kozman 4 th September 2015.
On-Line BankCard Center Presentation Cardholder Role During the Presentation click the mouse on this button to move back a slide During the Presentation.
Reporter Training for High School RIO TM
SET UP SERVICE HOURS HPHS FISH CAMP. COMMUNITY SERVICE BASICS You need 50 hours to graduate Must submit within 60 days of service Summer hours due October,
2017 AP® Preadministration Session
Dr Gareth James ASPC Audit lead
How to complete a Paper Application
Patient access – Ordering a prescription
Imaging requirements in ECST-2
Søren Marker Jensen, MD, coordinating investigator
Comments & Suggestions
Patient Participation meeting Monday 11 February 2013
Unit & District Tools Phase 1
REFLECT: Recovery Following Intensive Care Treatment
Registering for patient access
HOW TO ENTER EARLY WITHDRAWAL DATA
Final Report.
HOW TO ENTER END OF TRIAL DATA
MAINTAINING THE INVESTIGATOR’S SITE FILE
OCCC Filing I-765 Format.
Patient Access Forgotten user ID
Medication Reconciliation ROP Compliance
The early use of Antibiotics in at Risk CHildren with InfluEnza
Comments & Suggestions
HOW TO CONSENT A PATIENT?
For children born between 1st September 2013 and 31st August 2014
How to Submit a New Human Ethics Behavioral Application
The early use of Antibiotics in at Risk CHildren with InfluEnza
Continuous Improvement Planning – Informal Needs Assessment
ASCD 2012 Concurrent Presenter Information Meeting
We will begin the MaRISS Coordinator Call shortly…
Set Up Service Hours HPHS Fish Camp.
Investing in good health at work
Data Entry Interface (DEI) Overview
NextGen Purchasing Calendar Year End 1099 Process
A Managers Guide to Parental Leave
Clinical Trials Budgeting, Part 2
HOW TO SCREEN PATIENTS AND BOOK THE BASELINE VISIT APPOINTMENT?
NHS Adult Inpatient Survey 2018
HOW TO ENTER END OF TRIAL DATA
MAINTAINING THE INVESTIGATOR’S STUDY FILE
NesCom PAR Review Period Comment Dialog
Medication Reconciliation
2013 AP® Preadministration Session
Reporter Training for High School RIOTM
BE MORE INVOLVED IN YOUR HEALTH CARE
Academy Medical Centre
Dr Gareth James ASPC lead on Audit
Reporter Training for High School RIOTM
Dates to remember Family access both new and existing will stop August 31 All event registrations end August 31 County Dues information to state office.
Presentation transcript:

Aiming for complete data Alison Clarke & Wojtek Brudlo

ACST-2 overview 988 patients to go First patient randomised: 15/01/2008 Patients are now in their 9th year of follow-up 120 active centres from 32 countries 2612 patients recruited Goal: 3,600 patients 988 patients to go

Initial forms received Randomised Consent Randomisation 1-month Follow-up (of expected) 2612 (100%) 97.3% 97.6% 95.8% Verified 97.0% 93.3% 88 forms with outstanding data queries 111 1-month forms still overdue (16 over 2 years!) We would like you to return the forms: Consent and Randomisation Forms – 1 week after randomisation One Month Follow-up Form – 30 days after the procedure (after Doppler + outpatient appointment)

Annual follow-ups Year Forms sent Forms received (of expected) 2016 1867 94.5% 2017 2107 53.8% Aim - at least 96% of Annual Follow-ups Collaborators are responsible for 40% 11th September 2017 – 1st reminder to patients We are still expecting 964 forms If you haven’t returned these, please do it soon!!!

Consent Form What we need, please: Dates must match! On the day, patient and COLLABORATOR must sign – form must NOT be signed by a relative Please make sure patients DO NOT put their Date of Birth Please provide addresses for patient, patient’s GP, and alternative contacts Write patient ID & Procedure

IMPORTANT DO NOT randomise before patient has signed consent Please use the correct consent form (approved by your local Ethics committee) If you’re anonymising patients (DE, A, CH), remember to remove names and signatures before sending us the consent

Randomisation Form Write patient ID and procedure here Please complete all this before randomisation! Please indicate using numbers 0 if ‘no’ or 1, 2, or 3 Required for Form Submission. Can be completed after randomisation. Please do not leave empty boxes!

1-month post-procedure form Complete all the items with details about the procedure (CAS or CEA) and the name of the surgeon or interventionalist If a patient has MI, stroke or death tell us right away. Indicate what event occurred (might happen in hospital or at home) and provide as much detail as possible. Send the form to our office. It is compulsory that we have the date of duplex and % of stenosis. Answer all of these questions And provide the date the patient was last seen

Annual form

Why do we want complete data? Primary end point MAJOR EVENTS Within 30 days Stroke and death more than 30 days Research Responsibility to the patients Present accurate data on the study If we don’t provide the data why do the research?

Major events within 30 days of treatment Stroke, MI and Death Might be whilst they are still in your care at the hospital Might be in the days after discharge Still need the information Type of information we need: Imaging reports discharge summary echocardiogram cause of death

Major Events after 30 days Stroke and death ACST-2 office often know before centres Need the centres to fill in the blanks imaging reports date and cause of death Because the centre is the last to know it makes it harder to find information!

Does having the major event information make a difference? 526 patients fill in different areas on this form suggesting that that they had a stroke. If we believe all 526 patients that they had a stroke then the stroke rate would be 25% However the centres provide information which confirms that only 4 patients have had a stroke then the stroke rate is 0.2% So having the correct information makes a difference

Dates and data 1 month form sent to the office has the date the patient was last seen was 24th October 2016 The 2017 annual follow up form returned by patients wife saying patient died 19th October 2016 Who is right??? These are further examples of where having the correct data makes a difference. Dates play an important role The implications of this are vast – Major event info, to altering the 1 month data that we present

Dates and data Collaborator had kindly been filling in the annual follow up form for a patient as ACST-2 office not getting any reply from the patient for a couple of years Finally the ACST-2 office get a response from the patients relative asking us to “stop sending the questionnaire the patient died 4 years ago!” Another example and there have been 4 or 5 instances where this has happened. The collaborator is relying on information from the hospital systems which might not be up to date

Key Dates we look for Consent Date of procedure Date last seen Before the patient is randomised Date of procedure After date of consent and randomisation Date last seen Usually at least 30 days after the procedure Date of last annual follow up So when we are looking for complete and accurate data we look at the following

Data from annual follow up A bad year 2014 Annual follow up forms sent 1273 Annual follow up forms received 946 So we can say that in 2014 785 patients AP only 57 AC only 22 Both AC and AP 842 AC or AP, not Both 41 Neither AC nor AP Blank medication Data We struggled to get follow up forms back from patients as well as collaborators.

Data from annual follow up A good year 2015 Annual follow up forms sent 1564 Annual follow up forms received 1430 So we can say that in 2015 1211patients AP only 74 AC only 37 Both AC and AP 1285 AC or AP, not Both 78 Neither AC nor AP 23 Blank medication Data

Research questions Medication Yes patients are on medication or 1336 patients on a lipid lowering medication 662 on Atorvastatin 180 patients are taking 40mg of Atorvastatin So by asking as Wojtek has already highlighted, by asking for the statin dose on the annual follow up we actually add to the body of research in this area and maybe influence statin regimes going forward

Thank you